Ignite Creation Date:
2024-05-06 @ 3:57 AM
Last Modification Date:
2024-10-26 @ 11:41 AM
Study NCT ID:
NCT02410733
Status:
COMPLETED
Last Update Posted:
2023-07-19
First Post:
2015-03-24
Brief Title:
Evaluation of the Safety and Tolerability of iv Administration of a Cancer Vaccine in Patients With Advanced Melanoma
Sponsor:
BioNTech SE
Organization:
BioNTech SE
Organization Data
Organization:
BioNTech SE
Class:
INDUSTRY
Study ID:
RB_0003-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BioNTech SE
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None